Cargando…
“DEPHENCE” system—a novel regimen of therapy that is urgently needed in the high-grade serous ovarian cancer—a focus on anti-cancer stem cell and anti-tumor microenvironment targeted therapies
Ovarian cancer, especially high-grade serous type, is the most lethal gynecological malignancy. The lack of screening programs and the scarcity of symptomatology result in the late diagnosis in about 75% of affected women. Despite very demanding and aggressive surgical treatment, multiple-line chemo...
Autores principales: | Wilczyński, Jacek R., Wilczyński, Miłosz, Paradowska, Edyta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10338102/ https://www.ncbi.nlm.nih.gov/pubmed/37448521 http://dx.doi.org/10.3389/fonc.2023.1201497 |
Ejemplares similares
-
Cancer Stem Cells in Ovarian Cancer—A Source of Tumor Success and a Challenging Target for Novel Therapies
por: Wilczyński, Jacek R, et al.
Publicado: (2022) -
Endometriosis Stem Cells as a Possible Main Target for Carcinogenesis of Endometriosis-Associated Ovarian Cancer (EAOC)
por: Wilczyński, Jacek R., et al.
Publicado: (2022) -
Detection and genotyping of CMV and HPV in tumors and fallopian tubes from epithelial ovarian cancer patients
por: Paradowska, Edyta, et al.
Publicado: (2019) -
The Toll-like Receptor 4 Polymorphism Asp299Gly Is Associated with an Increased Risk of Ovarian Cancer
por: Kania, Katarzyna D., et al.
Publicado: (2022) -
Factors in Oncogenesis: Viral Infections in Ovarian Cancer
por: Pathak, Sudipta, et al.
Publicado: (2020)